Trial intelligence / Profile preview

Bioavailability of DFN-15 in healthy adults

NCT03051685Phase 1Completed

Sponsor
Dr. Reddy's Laboratories
Start
Jul 2015
Primary completion
Aug 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of celecoxib oral solution in acute pain (4 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Pharmacokinetic parameters of DFN-15 up to 72 hours. Started Jul 2015; status: completed.

02

Drugs

celecoxib oral solution
03

Conditions

acute pain

Beyond the preview

Go deeper on NCT03051685.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03051685.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call